3 resultsfor “NHS drug pricing NICE independence”
NHS](https://www.theguardian.com/society/nhs) to buy – and thus which patients can receive – in England and Wales. Nice is widely viewed internationally as a model of how to protect against drug companies charging excessive prices. Labour
drugs have been available in a limited way since 2019 and 2021 respectively. NHS England has struck a price agreement with their manufacturers – Biogen (nusinersen) and Roche Pharmaceuticals (risdiplam) – to make them routinely available
Nice’s longstanding independence as the body that decides which drugs the NHS in England and Wales should buy is part of the government’s medicines agreement with the Trump administration which was announced last